A detailed history of Alliancebernstein L.P. transactions in Icon PLC stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,402,057 shares of ICLR stock, worth $400 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,402,057
Previous 1,474,610 4.92%
Holding current value
$400 Million
Previous $495 Million 11.28%
% of portfolio
0.16%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$288.23 - $331.73 $20.9 Million - $24.1 Million
-72,553 Reduced 4.92%
1,402,057 $440 Million
Q1 2024

May 14, 2024

SELL
$247.84 - $340.0 $15.4 Million - $21.2 Million
-62,303 Reduced 4.05%
1,474,610 $495 Million
Q4 2023

Feb 14, 2024

BUY
$222.83 - $285.76 $19.5 Million - $25 Million
87,409 Added 6.03%
1,536,913 $435 Million
Q3 2023

Nov 14, 2023

SELL
$236.44 - $265.62 $10.6 Million - $11.9 Million
-44,927 Reduced 3.01%
1,449,504 $357 Million
Q2 2023

Aug 15, 2023

SELL
$183.12 - $250.2 $35 Million - $47.8 Million
-190,969 Reduced 11.33%
1,494,431 $374 Million
Q1 2023

May 15, 2023

BUY
$193.59 - $245.33 $66.3 Million - $84.1 Million
342,625 Added 25.52%
1,685,400 $360 Million
Q4 2022

Feb 14, 2023

BUY
$173.9 - $224.8 $60.3 Million - $77.9 Million
346,575 Added 34.79%
1,342,775 $261 Million
Q3 2022

Nov 15, 2022

BUY
$183.25 - $247.5 $90.1 Million - $122 Million
491,763 Added 97.49%
996,200 $183 Million
Q2 2022

Aug 15, 2022

SELL
$197.3 - $261.32 $14.8 Million - $19.6 Million
-74,943 Reduced 12.94%
504,437 $109 Million
Q1 2022

May 13, 2022

BUY
$216.09 - $296.03 $6 Million - $8.23 Million
27,787 Added 5.04%
579,380 $141 Million
Q4 2021

Feb 14, 2022

BUY
$258.11 - $309.7 $9.8 Million - $11.8 Million
37,979 Added 7.39%
551,593 $171 Million
Q3 2021

Nov 10, 2021

BUY
$208.53 - $283.04 $10.4 Million - $14.2 Million
50,075 Added 10.8%
513,614 $135 Million
Q2 2021

Jul 30, 2021

SELL
$194.07 - $232.2 $21.7 Million - $26 Million
-111,963 Reduced 19.45%
463,539 $95.8 Million
Q1 2021

May 06, 2021

SELL
$171.87 - $220.96 $170 Million - $219 Million
-989,811 Reduced 63.23%
575,502 $113 Million
Q4 2020

Feb 08, 2021

SELL
$180.3 - $214.08 $41.2 Million - $48.9 Million
-228,523 Reduced 12.74%
1,565,313 $305 Million
Q3 2020

Nov 12, 2020

BUY
$166.91 - $196.1 $11.4 Million - $13.4 Million
68,580 Added 3.98%
1,793,836 $343 Million
Q2 2020

Aug 13, 2020

SELL
$129.79 - $170.94 $21.5 Million - $28.3 Million
-165,686 Reduced 8.76%
1,725,256 $291 Million
Q1 2020

May 14, 2020

SELL
$115.95 - $177.22 $26.5 Million - $40.5 Million
-228,475 Reduced 10.78%
1,890,942 $257 Million
Q4 2019

Feb 18, 2020

SELL
$139.48 - $172.23 $7.2 Million - $8.89 Million
-51,625 Reduced 2.38%
2,119,417 $365 Million
Q3 2019

Nov 14, 2019

BUY
$146.89 - $161.41 $1.8 Million - $1.97 Million
12,221 Added 0.57%
2,171,042 $320 Million
Q2 2019

Aug 14, 2019

BUY
$129.99 - $153.97 $6.64 Million - $7.87 Million
51,098 Added 2.42%
2,158,821 $332 Million
Q1 2019

May 14, 2019

SELL
$121.3 - $146.95 $24 Million - $29.1 Million
-198,189 Reduced 8.59%
2,107,723 $288 Million
Q4 2018

Feb 13, 2019

SELL
$119.37 - $153.29 $45.5 Million - $58.5 Million
-381,488 Reduced 14.2%
2,305,912 $298 Million
Q3 2018

Nov 08, 2018

SELL
$131.3 - $153.75 $18.6 Million - $21.7 Million
-141,378 Reduced 5.0%
2,687,400 $413 Million
Q2 2018

Aug 13, 2018

BUY
$111.38 - $137.03 $21.2 Million - $26.1 Million
190,348 Added 7.21%
2,828,778 $375 Million
Q1 2018

May 14, 2018

BUY
$103.82 - $123.9 $8.1 Million - $9.67 Million
78,063 Added 3.05%
2,638,430 $312 Million
Q4 2017

Feb 13, 2018

BUY
$111.14 - $123.05 $2.73 Million - $3.02 Million
24,571 Added 0.97%
2,560,367 $287 Million
Q3 2017

Nov 13, 2017

BUY
$101.4 - $116.62 $257 Million - $296 Million
2,535,796
2,535,796 $289 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $23.3B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.